Martin Steiner

Chief Executive Officer at

SYNIMMUNE GmbH

Commercial Services

Consumer Services

Health Technology

Profile

Martin Steiner is the founder of ImVisioN Therapeutics AG, which was founded in 2008.
He held the position of Director, Chief Executive & Financial Officer from 2011 to 2014.
Dr. Steiner is currently the President, Secretary, Treasurer & Director at ImVision Therapeutics, Inc. and Co-Managing Director at SYNIMMUNE GmbH since 2016.
In the past, he was the Chief Executive Officer at Apovia AG from 1997 to 2004 and Director-Business Development at Smithkline Beecham Biologicals Immunotherapeutics in 1997.
Dr. Steiner was also the Chief Executive & Financial Officer at ImVisioN GmbH.
Dr. Steiner holds an MBA from the University of Michigan and a doctorate from the University of Vienna.

Martin Steiner active positions

Companies	Position	Start
ImVision Therapeutics, Inc. ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies	President	-
SYNIMMUNE GmbH SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies	Chief Executive Officer	29/02/2016

All active positions of Martin Steiner

Former positions of Martin Steiner

Companies	Position	End
ImVisioN Therapeutics AG ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy	Chief Executive Officer	12/02/2014
Apovia AG	President	31/12/2003
Smithkline Beecham Biologicals Immunotherapeutics	Corporate Officer/Principal	31/12/1996
ImVisioN GmbH ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy	Chief Executive Officer	-

See the detail of Martin Steiner's experience

Training of Martin Steiner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Steiner's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
ImVision Therapeutics, Inc. ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies	Health Technology
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Vienna University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ImVisioN GmbH ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy	Commercial Services
Apovia AG
ImVisioN Therapeutics AG ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy	Commercial Services
Smithkline Beecham Biologicals Immunotherapeutics
SYNIMMUNE GmbH SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies	Commercial Services